Soligenix announces positive results for ricin vaccine; MMR vaccination rates fall just shy of CDC's goal;

> The Centers for Disease Control and Prevention recommends that adults receive the whooping cough vaccine. Story

> India's New Drugs Advisory Committee of Vaccine approved 9 proposals for trials and market authorizations. News

> MMR vaccination rates fell just shy of the CDC's goals for children starting kindergarten. Article

> NIH scientists gained a new understanding of the first steps in flu antibody development. Release

> Soligenix announced positive Phase Ib clinical results with RiVax, its vaccine against ricin exposure. Release

And Finally... Researchers at the University of Cape Town in South Africa have pioneered a new drug that could serve as a single-dose malaria vaccine. More

Suggested Articles

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.

Takeda has spent considerable resources on its phase 3 dengue vaccine, and now data show the shot was 80% effective in preventing dengue.